Skip to main content
Log in

Non-Steroidal Anti-Inflammatory Drugs and Risk of Acute Kidney Injury and Hyperkalemia in Older Adults: A Retrospective Cohort Study and External Validation of a Clinical Risk Model

  • Original Research Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

Aim

Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used analgesics among older adults. Adverse effects may be avoided by careful patient selection. We aimed to evaluate the incidence of acute kidney injury (AKI) and/or hyperkalemia, risk factors, and the accuracy of an NSAID risk prediction model in a cohort of Asian older adults.

Methods

We conducted a retrospective cohort study of older adults, age 65 years and above, who received prescriptions between March 2015 and December 2017 from Singapore’s largest cluster of public healthcare institutions. Factors associated with 30-day incident acute kidney injury and/or hyperkalemia were evaluated with multivariable regression analysis. Calibration and discrimination of the Nash prediction model were assessed using the Hosmer-Lemeshow goodness-of-fit test and C-statistic, respectively.

Results

The primary outcome occurred in 16.7% of 12,798 older adults. Topical NSAIDs (adjusted OR 1.29, 95% CI 1.15–1.45), systemic NSAIDs of 1–14 days’ duration (adjusted OR 1.43, 95% CI 1.27–1.62), and systemic NSAIDs > 14 days (adjusted OR 1.84, 95% CI 1.37–2.49) were independently associated with the primary outcome, compared with no NSAID. Diabetes mellitus, cardiovascular disease, lower estimated glomerular filtration rate (eGFR), and diuretics were also independently associated with increased incident AKI and/or hyperkalemia. When applied to older adults with systemic NSAIDs > 14 days (n = 305), the Nash risk model had poor calibration (p < 0.001) and poor discrimination with C-statistic 0.527 (0.438, 0.616).

Conclusions

Longer NSAID duration and systemic compared with topical route were associated with incremental odds for acute renal events. Further studies are required to improve the available risk model to guide NSAID prescriptions in older adults.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
€32.70 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Austria)

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Panel AGSBCUE, Fick DM, Semla TP, et al. American Geriatrics Society 2019 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674–94.

    Article  Google Scholar 

  2. Kuhn-Thiel AM, Weiß C, Wehling M. Consensus validation of the FORTA (Fit fOR The Aged) list: a clinical tool for increasing the appropriateness of pharmacotherapy in the elderly. Drugs Aging. 2014;31(2):131–40.

    Article  CAS  Google Scholar 

  3. Zhang X, Donnan PT, Bell S, Guthrie B. Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: systematic review and meta-analysis. BMC Nephrol. 2017;18(1):256.

    Article  Google Scholar 

  4. O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–8.

    Article  Google Scholar 

  5. Nash DM, Markle-Reid M, Brimble KS, et al. Nonsteroidal anti-inflammatory drug use and risk of acute kidney injury and hyperkalemia in older adults: a population-based study. Nephrol Dial Transplant. 2019;34(7):1145–54.

    Article  Google Scholar 

  6. Lim CC, Tan NC, Ang A, Quek N, Choo J. To give or not to give: no dearth of explicit guidelines on potentially inappropriate prescribing of non-steroidal anti-inflammatory drugs to older adults. Intern Med J. 2019;49(11):1461–2.

    Article  Google Scholar 

  7. Chou C-I, Shih C-J, Chen Y-T, et al. Adverse effects of oral nonselective and cyclooxygenase-2-selective NSAIDs on hospitalization for acute kidney injury: a nested case–control cohort study. Medicine. 2016;95(9):e2645.

    Article  CAS  Google Scholar 

  8. Lim CC, Ang ATW, Kadir HBA, et al. Short-course systemic and topical non-steroidal anti-inflammatory drugs: impact on adverse renal events in older adults with co-morbid disease. Drugs Aging. 2021;38(2):147–56.

    Article  CAS  Google Scholar 

  9. Lapi F, Azoulay L, Yin H, Nessim SJ, Suissa S. Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study. BMJ (Clinical research ed). 2013;346. https://doi.org/10.1136/bmj.e8525.

  10. Dreischulte T, Morales DR, Bell S, Guthrie B. Combined use of nonsteroidal anti-inflammatory drugs with diuretics and/or renin–angiotensin system inhibitors in the community increases the risk of acute kidney injury. Kidney Int. 2015;88(2):396–403.

    Article  CAS  Google Scholar 

  11. Kellum JA, Lameire N, Aspelin P, et al. Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(1):1–138.

    Article  Google Scholar 

  12. Schneider V, Lévesque LE, Zhang B, Hutchinson T, Brophy JM. Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: a population-based, nested case-control analysis. Am J Epidemiol. 2006;164(9):881–9.

    Article  Google Scholar 

  13. Griffin MR, Yared A, Ray WA. Nonsteroidal antiinflammatory drugs and acute renal failure in elderly persons. Am J Epidemiol. 2000;151(5):488–96.

    Article  CAS  Google Scholar 

  14. R: A Language and Environment for Statistical Computing [Internet] [computer program]. Vienna: R Foundation for Statistical Computing; 2020.

  15. Lele SR KJ, Solymos P. ResourceSelection: Resource selection (probability) functions for use-availability data [Internet]. 2019.

  16. Robin XTN, Hainard A, Tiberti N, Lisacek F, Sanchez J-C, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform. 2011;12(1):1–8.

    Article  Google Scholar 

  17. Austin PC, Steyerberg EW. Graphical assessment of internal and external calibration of logistic regression models by using loess smoothers. Stat Med. 2014;33(3):517–35.

    Article  Google Scholar 

  18. Nishtala PS, Chyou T. Identifying drug combinations associated with acute kidney injury using association rules method. Pharmacoepidemiol Drug Saf. 2020;29(4):467–73.

    Article  CAS  Google Scholar 

  19. Solomon DH, Husni ME, Wolski KE, et al. Differences in safety of nonsteroidal antiinflammatory drugs in patients with osteoarthritis and patients with rheumatoid arthritis: a randomized clinical trial. Arthritis Rheumatol (Hoboken, NJ). 2018;70(4):537–46.

    Article  CAS  Google Scholar 

  20. Kate RJ, Perez RM, Mazumdar D, Pasupathy KS, Nilakantan V. Prediction and detection models for acute kidney injury in hospitalized older adults. BMC Med Inform Decis Mak. 2016;16(1):39–39.

    Article  Google Scholar 

  21. Bally M, Dendukuri N, Rich B, et al. Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data. BMJ (Clinical research ed). 2017;357:j1909.

    Article  Google Scholar 

  22. Horl WH. Nonsteroidal anti-inflammatory drugs and the kidney. Pharmaceuticals (Basel, Switzerland). 2010;3(7):2291–321.

    Article  Google Scholar 

  23. Zhan M, Doerfler RM, Xie D, et al. Association of opioids and nonsteroidal anti-inflammatory drugs with outcomes in CKD: findings from the CRIC (Chronic Renal Insufficiency Cohort) Study. Am J Kidney Dis. 2020;76(2):184–93.

    Article  CAS  Google Scholar 

  24. Panel BtAGSBCUE. American Geriatrics Society 2019 Updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674–94.

    Article  Google Scholar 

  25. Wynants L, van Smeden M, McLernon DJ, et al. Three myths about risk thresholds for prediction models. BMC Med. 2019;17(1):192–192.

    Article  Google Scholar 

  26. Altman RD. New guidelines for topical NSAIDs in the osteoarthritis treatment paradigm. Curr Med Res Opin. 2010;26(12):2871–6.

    Article  CAS  Google Scholar 

  27. Zeng C, Wei J, Persson MS, et al. Relative efficacy and safety of topical non-steroidal anti-inflammatory drugs for osteoarthritis: a systematic review and network meta-analysis of randomised controlled trials and observational studies. Br J Sports Med. 2018;52(10):642–50.

    Article  Google Scholar 

  28. Suissa S. Immortal time bias in pharmacoepidemiology. Am J Epidemiol. 2008;167(4):492–9.

    Article  Google Scholar 

  29. Katsuno T, Togo K, Ebata N, et al. Burden of renal events associated with nonsteroidal anti-inflammatory drugs in patients with osteoarthritis and chronic low back pain: a retrospective database study. Pain Ther. 2021;10(1):443–55.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cynthia Ciwei Lim.

Ethics declarations

Funding

This research was supported by the SHF-Foundation Research Grant (SHF/HSRHO014/2017).

Conflict of interest

All authors declare no relevant conflict of interest.

Ethics approval

This study was conducted according to the Declaration of Helsinki.

Consent

Waiver of informed consent for the use of de-identified electronic medical record data was approved by the SingHealth Centralized Institutional Board (2018/2567).

Consent for publication

Not applicable.

Data availability statement

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available because data sharing will be subject to institutional approval.

Code availability

Not applicable.

Author contributions

CCL, TNC, and JC conceptualized and designed the study; CL, TNC, HAK, and AA obtained data; CL and ET analyzed and interpreted the data; CL wrote the first draft; all authors contributed to and approved the final version of this manuscript for submission.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 167 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lim, C.C., Tan, N.C., Teo, E.P.S. et al. Non-Steroidal Anti-Inflammatory Drugs and Risk of Acute Kidney Injury and Hyperkalemia in Older Adults: A Retrospective Cohort Study and External Validation of a Clinical Risk Model. Drugs Aging 39, 75–82 (2022). https://doi.org/10.1007/s40266-021-00907-w

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40266-021-00907-w

Navigation